Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
4596.T
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.23
N/A
-5.06
vs -9.44
Q4.23
N/A
-6.28
vs -6.23
Q1.24
N/A
-6.10
vs -8.09
Q2.24
N/A
-5.80
vs -5.40
Q3.24
N/A
-5.87
vs -5.06
Q4.24
N/A
-5.89
vs -6.28
Q1.25
N/A
-4.49
vs -6.10
Sales Growth
YoY
Current
Estimates
Q3.23
+365%
13.3M vs 2.9M
Q4.23
+73%
9.3M vs 5.4M
Q1.24
-3%
5M vs 5.2M
Q2.24
-61%
4.7M vs 12.1M
Q3.24
-45%
7.4M vs 13.3M
Q4.24
+8%
10M vs 9.3M
Q1.25
+44%
7.2M vs 5M
Return on Equity
QoQ
Q2.23
-9%
-0.09
vs -0.12
Q3.23
-9%
-0.09
vs -0.09
Q4.23
-17%
-0.17
vs -0.09
Q1.24
-15%
-0.15
vs -0.17
Q2.24
-16%
-0.16
vs -0.15
Q3.24
-20%
-0.20
vs -0.16
Q4.24
-24%
-0.24
vs -0.20
Q1.25
-21%
-0.21
vs -0.24
Institutionnal Ownership
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Relative Strength
4596.T
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device patient-based ophthalmology suite, that includes home-based miniature and NASA high-res version optical coherence tomography devices; and wearable device for myopia control. The company was founded in 2002 and is based in Tokyo, Japan.
JPX
Unprofitable
EPS improving
Unprofitable
EPS improving
1.00Â ( 1.96%)
Relative Strenght
Volume Buzz
-3%
Earning Acce
No
Dist 52w H.
45%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 4596.T compares to sector?
4596.T
-2x